Consider V.A.C. Therapy: A Solution Associated with Fewer Amputations
Data calculated at the end of 112 days of active therapy phase from two randomized controlled trials consistently demonstrated that V.A.C. Therapy can result in fewer amputations compared to advanced moist wound therapy.
- Blume et al. reported that diabetic foot ulcer patients treated with V.A.C. Therapy experienced significantly fewer secondary amputations (7/169, 4.1%,) compared to AMWT* (17/166,10.2%; p=0.035).5
- Armstrong reported that diabetic foot amputation wound patients treated with V.A.C. Therapy showed a trend toward fewer secondary amputations.3
- Fewer V.A.C. Therapy patients (2/77; 3%,) underwent a second amputation compared to AMWT* patients (9/85; 11%; p=0.060)
- No high level (above-foot) amputations (0/77, 0%) in the V.A.C. Therapy group vs. 5/85 (6%) in the AMWT* group.
- V.A.C. Therapy patients were less than a fourth as likely as AMWT* patients to need a second amputation.
